| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/10/2013 | EP2576619A1 Humanised antigen binding proteins to myostatin6 |
| 04/10/2013 | EP2576618A1 Antibodies to human gdf8 |
| 04/10/2013 | EP2576617A2 MONOCLONAL ANTIBODIES TARGETING Aß OLIGOMERS |
| 04/10/2013 | EP2576616A2 Method for preparing antibodies having improved properties |
| 04/10/2013 | EP2576615A2 Fibronectin based scaffold proteins having improved stability |
| 04/10/2013 | EP2576614A2 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis |
| 04/10/2013 | EP2576611A2 Sulfation of wnt pathway proteins |
| 04/10/2013 | EP2575884A2 Uses and compositions for treatment of hidradenitis suppurativa (hs) |
| 04/10/2013 | EP2575882A2 Humanized monoclonal antibodies and methods of use |
| 04/10/2013 | EP2575881A1 Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis |
| 04/10/2013 | EP2575880A2 Monoclonal antibodies against her2 epitope |
| 04/10/2013 | EP2575879A1 Novel anti-cmet antibody |
| 04/10/2013 | EP2575863A2 Use of the sparc microenvironment signature in the treatment of cancer |
| 04/10/2013 | EP2575857A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
| 04/10/2013 | EP2575856A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases |
| 04/10/2013 | EP2575762A2 Removal of serine proteases by treatment with finely divided silicon dioxide |
| 04/10/2013 | CN103038350A Cloning and exploitation of a functional R-gene from solanum X edinense |
| 04/10/2013 | CN103038258A Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (LRP6) antibodies |
| 04/10/2013 | CN103038257A Anti-VLA-4 antibodies |
| 04/10/2013 | CN103038256A Methods and compositions for treating hepatitis with anti-CD3 immune molecule therapy |
| 04/10/2013 | CN103038255A Novel anti-CD98 antibody and use thereof |
| 04/10/2013 | CN103038254A Antagonist anti-il-7 receptor antibodies and methods |
| 04/10/2013 | CN103037900A Folate receptor 1 antibodies and immunoconjugates and uses thereof |
| 04/10/2013 | CN103037890A Dendritic cell inhibitory proteins from ticks |
| 04/10/2013 | CN103030696A Antibodies and immunoconjugates and uses therefor |
| 04/10/2013 | CN103030695A Anti c-met humanized antibody and uses thereof |
| 04/10/2013 | CN103030694A Preparation method of yolk immunoglobulin for preventing and treating escherichia coli-induced diarrhea of piglets |
| 04/10/2013 | CN103030693A Neutralization molecule of high-pathogenicity avian influenza and preparation method thereof |
| 04/10/2013 | CN102296052B Specific antigenic peptide of polyclonal antibody aiming at ppGalNAc-T13, and its preparation method and use |
| 04/10/2013 | CN102229671B Anti-IMMT anthropogenic Fab antibody and application thereof in preparing anti-liver cancer drugs |
| 04/10/2013 | CN102180969B Monoclonal antibody with liver cancer resisting activity and application thereof |
| 04/10/2013 | CN102174106B Anti-Met humanized Fab, anti-Met humanized Fab and doxorubicin conjugate and preparation method and application of anti-Met humanized Fab and doxorubicin conjugate |
| 04/10/2013 | CN102153628B Alpha1-antitrypsin polyclonal antibody and application of alpha1-antitrypsin polyclonal antibody and polypeptide for alpha1-antitrypsin polyclonal antibody |
| 04/10/2013 | CN102012429B Aeromonas hydrophila aerolysin Dot-ELISA detection method |
| 04/10/2013 | CN101863978B Human source anti-rabies virus Fab antibody, cross linking method thereof with nanometer particles and application thereof |
| 04/10/2013 | CN101821291B Compositions and methods for use for antibodies against sclerostin |
| 04/10/2013 | CN101802193B Cancer diagnosis kit and cancer diagnosis method |
| 04/10/2013 | CN101692092B Method for quantitatively detecting alpha-synuclein auto-antibodies in human sera |
| 04/10/2013 | CN101541835B Anti-idiotype conjugate and its use as a standard in an immunassay |
| 04/10/2013 | CN101415730B Compositions and methods of use for antibodies of c-Met |
| 04/10/2013 | CN101245108B Antihuman CD34 antibody, producing process and uses thereof |
| 04/10/2013 | CN101046476B Application of specific identification tau antibody, and reagent kit containing thereof |
| 04/10/2013 | CN101035804B Modified HIV-1 peptides and use thereof in the detection of anti-HIV antibodies |
| 04/09/2013 | US8415460 Methods of making antibodies specific for cysteine-rich soluble protein C23 |
| 04/09/2013 | US8415459 Antibody to GDF8 and uses thereof |
| 04/09/2013 | US8415303 Method of treatment using a soluble human delta protein fragment |
| 04/09/2013 | US8415296 Oxyntomodulin peptide analogue |
| 04/09/2013 | US8415291 Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses |
| 04/09/2013 | US8415113 Diagnostic method for detecting disturbances of the pancreas |
| 04/09/2013 | US8415095 Use of nucleoside derivatives comprising a citrate group for the production of antibodies having an affinity for triphosphorylated nucleosides |
| 04/09/2013 | US8414901 Canine Lyme disease vaccine |
| 04/09/2013 | US8414898 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 04/09/2013 | US8414896 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 04/09/2013 | US8414895 Tweak receptor |
| 04/09/2013 | US8414894 Human antibodies that bind human TNFα and methods of using same |
| 04/09/2013 | US8414893 Anti-amyloid antibodies and uses thereof |
| 04/09/2013 | US8414892 Uses of monoclonal antibody 8H9 |
| 04/09/2013 | US8414891 Method for treating pulmonary hypertension |
| 04/09/2013 | US8414890 Human antibodies to human RANKL, encoding nucleic acids and methods of treatment |
| 04/09/2013 | US8414889 Protective anti-glucan antibodies with preference for β-1,3-glucans |
| 04/09/2013 | US8414887 Methods for suppressing Toll-like Receptor 4 (TLR4) function using TLR14 antagonists |
| 04/09/2013 | CA2598454C Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues |
| 04/09/2013 | CA2567394C Glycoprotein vi antibodies and methods of use thereof |
| 04/09/2013 | CA2562771C Anti-il-9 antibody formulations and uses thereof |
| 04/09/2013 | CA2546406C Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 04/09/2013 | CA2455237C Compositions and methods for generating chimeric heteromultimers |
| 04/09/2013 | CA2288430C Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor |
| 04/09/2013 | CA2274319C Methods and compositions for polypeptide engineering |
| 04/04/2013 | WO2013049362A2 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis |
| 04/04/2013 | WO2013049278A1 USE OF IL-1 ß BINDING ANTIBODIES |
| 04/04/2013 | WO2013049254A1 Hybrid constant regions |
| 04/04/2013 | WO2013048883A2 Anti-erbb3 antibodies and uses thereof |
| 04/04/2013 | WO2013048243A1 Multi-specific binding molecules targeting aberrant cells |
| 04/04/2013 | WO2013047748A1 Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities |
| 04/04/2013 | WO2013047729A1 Antigen-binding molecule inducing immune response to target antigen |
| 04/04/2013 | WO2013046722A1 Ion concentration-dependent binding molecule library |
| 04/04/2013 | WO2013046704A2 THERAPEUTIC ANTIGEN-BINDING MOLECULE WITH A FcRn-BINDING DOMAIN THAT PROMOTES ANTIGEN CLEARANCE |
| 04/04/2013 | WO2013045934A2 Compositions comprising agents that inhibit neuropilin and tolloid like 2 |
| 04/04/2013 | WO2013045916A1 Chimaeric surrogate light chains (slc) comprising human vpreb |
| 04/04/2013 | WO2013045707A2 Biological materials related to c-met |
| 04/04/2013 | WO2013045580A1 Anti-icam-1 antibodies to treat multiple-myeloma related disorders |
| 04/04/2013 | WO2013045469A1 Igy composition for use in coeliac disease |
| 04/04/2013 | WO2013045404A2 Inhibition of the effect of interleukin 1 beta in order to treat endometriosis |
| 04/04/2013 | WO2013045125A1 Immunocytokine combination therapy |
| 04/04/2013 | WO2013045112A1 Particular uses of cd24 inhibitors |
| 04/04/2013 | WO2013044840A1 Neutralizing molecule of highly pathogenic avian influenza and preparation method therefor |
| 04/04/2013 | WO2013044575A1 Elisa kit for detecting polypeptide marker antigen |
| 04/04/2013 | WO2013044390A1 Increasing virus-like particle yield in plants |
| 04/04/2013 | WO2013044298A1 Antibodies against tl1a and uses thereof |
| 04/04/2013 | WO2013011076A3 Tnf -alpha antigen- binding proteins with increased fcrn binding |
| 04/04/2013 | WO2013009967A3 Identifying affinity-matured human antibodies |
| 04/04/2013 | WO2013004842A3 Antibody variants and uses thereof |
| 04/04/2013 | WO2012165926A3 Marker for diagnosing liver cancer containing anti-atic autoantibody, and composition for diagnosing liver cancer containing antigen thereof |
| 04/04/2013 | US20130086701 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 04/04/2013 | US20130085266 ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS |
| 04/04/2013 | US20130085265 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 04/04/2013 | US20130085262 Novel surface antigen |
| 04/04/2013 | US20130085072 Recombinant renewable polyclonal antibodies |
| 04/04/2013 | US20130084585 Immunoassay for chromogranin a, antibodies and kit |
| 04/04/2013 | US20130084301 Cluster of Neutralizing Antibodies to Hepatitis C Virus |